Premium
Expression of ksdD gene encoding 3‐ketosteroid‐Δ 1 ‐dehydrogenase from Arthrobacter simplex in Bacillus subtilis
Author(s) -
Li Y.,
Lu F.,
Sun T.,
Du L.
Publication year - 2007
Publication title -
letters in applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.698
H-Index - 110
eISSN - 1472-765X
pISSN - 0266-8254
DOI - 10.1111/j.1472-765x.2007.02134.x
Subject(s) - bacillus subtilis , transformation (genetics) , arthrobacter , ketosteroid , enzyme , recombinant dna , dehydrogenase , biochemistry , biology , biotransformation , microbiology and biotechnology , enzyme assay , escherichia coli , extracellular , bacillaceae , bacteria , gene , isomerase , genetics
Aims: To improve KSDH enzyme activity and the transformation level for androst‐4‐ene‐3,17‐dione. Methods and Results: 3‐ketosteroid‐Δ 1 ‐dehydrogenase gene from Arthrobacter simplex was expressed in Bacillus subtilis under the control of P43 promoter. The molecular weight of expressed enzyme was about 55 kDa by SDS–PAGE analysis. The activities of intracellular and extracellular soluble enzymes examined by spectrophotometrical method were 110 ± 0·5 mU mg −1 and 15 ± 0·6 mU mg −1 of protein, respectively. The transformation rate of androst‐4‐ene‐3,17‐dione was 45·3% in the B. subtilis recombinant cells. Conclusions: The enzyme activity of KSDH expressed in B. subtilis was improved about 30‐fold compared with that of Arthrobacter simplex , and the transformation level of androst‐4‐ene‐3,17‐dione by the B. subtilis recombinant cells was improved about 10‐fold. Significance and Impact of the Study: The recombinant B. subtilis cells used for biotransformation of steroids provide a new method for production of steroid medicine. The time required for transformation of B. subtilis is much shorter than that of other bacteria, which means it will have wider usage in biopharmaceutical industry.